e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Therapeutic approaches in inflammatory lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
No shunting towards LTB4 when blocking LTC4s in vitro
Pernilla Glader (Mölndal, Sweden), Pernilla Glader, Swedin Linda, Wissing Britt-Marie, Göransson Melker, Davis Andy
Source:
International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Session:
Therapeutic approaches in inflammatory lung disease
Session type:
Thematic Poster Session
Number:
3892
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pernilla Glader (Mölndal, Sweden), Pernilla Glader, Swedin Linda, Wissing Britt-Marie, Göransson Melker, Davis Andy. No shunting towards LTB4 when blocking LTC4s in vitro. Eur Respir J 2015; 46: Suppl. 59, 3892
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
IL5 and IL13 modulate trans-compartmental activation and migration of eosinophils
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
shRNA suppresses of IL-13 production in vitro
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
Dual role of M2 macrophages in asthma
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Blood cytotoxic/pro-inflammatory mediators in severe asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Structural alterations and endothelial activation in pulmonary and bronchial vessels of asthmatics
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
The polyamine spermine inhibits mitochondrial permeability transition (mPT) and apoptosis in human eosinophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Impaired synthesis and transport of immunoglobulin A in severe asthma: Role of IL-13
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Immune modulation of the T-cell response in asthma through Wnt10b
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Direct relationship between inhibition of leukotriene release in lung and free plasma concentration of a LTC4 synthase inhibitor in a rat model
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Expression of CysLT
2
receptors in asthmatic lung, and the roles in bronchoconstriction
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Characterization QAW039 and QAV680, two novel, potent and selective CRTh2 antagonists
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014
Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA)
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept